Docimo G, Tolone S, Ruggiero R, Gubitosi A, Pasquali D, De Bellis A, Limongelli P, Del Genio G, Docimo L, Conzo G
Division of General Surgery, Department of Surgery, Second University of Naples, Naples, Italy -
Minerva Chir. 2013 Jun;68(3):321-8.
Routine central neck dissection for differentiated thyroid cancer (DTC) to prevent a future recurrence is still a matter of discussion, due to the increased risk of injury to parathyroid glands, without a clear demonstrable benefits in terms of long-term survival. Aim of this study was to investigate if, treating patients with total thyroidectomy (TT) without prophylactic central lymphadenectomy can minimize the risk of hypocalcemia by routine administration of oral calcium and vitamin D supplements, providing at the same time a low recurrence rate.
In the set of a retrospective study, 221 patients affected by DTC were enrolled. All of them underwent to TT without prophylactic central lymphadenectomy. In the early postoperative period, oral calcium 2g/d taken twice (1 g every 12 hours) and vitamin D 1 g/d taken twice (0.5 g every 12 hours) were administered; changes in serum calcium and hypocalcemia-related symptoms were recorded. Follow-up was based on neck ultrasound and monitoring of serum Tg and Tg-antibodies levels every 6 months during suppressive l-tiroxine treatment.
Symptomatic hypocalcemia developed only in 6.3% of patients, whereas laboratory hypocalcemia developed in 10%. Hypocalcemic symptoms were minimal in 4 patients. Intravenous calcium was administered to 6 patients with severe hypocalcemic symptoms. Permanent hypocalcemia developed in two patients.
Until a conclusive evidence of the actual benefit of prophylactic central lymphadenectomy in the treatment of DTC, it may be avoided. The oral calcium and vitamin D supplements can take a role in the prevention of postoperative hypocalcemia and for increasing the likelihood of a safe and early discharge from the hospital.
对于分化型甲状腺癌(DTC),常规进行中央区颈部淋巴结清扫以预防未来复发仍是一个有争议的问题,因为甲状旁腺损伤风险增加,且在长期生存方面没有明确的可证明益处。本研究的目的是调查在不进行预防性中央区淋巴结清扫的情况下,对患者进行全甲状腺切除术(TT),通过常规口服钙和维生素D补充剂是否可以将低钙血症风险降至最低,同时保持低复发率。
在一项回顾性研究中,纳入了221例DTC患者。他们均接受了TT且未进行预防性中央区淋巴结清扫。术后早期,给予口服钙2g/d,分两次服用(每12小时1g),维生素D 1g/d,分两次服用(每12小时0.5g);记录血清钙的变化和与低钙血症相关的症状。随访基于颈部超声以及在进行左旋甲状腺素抑制治疗期间每6个月监测血清Tg和Tg抗体水平。
仅6.3%的患者出现症状性低钙血症,而实验室检查发现低钙血症的患者为10%。4例患者的低钙血症症状轻微。6例有严重低钙血症症状的患者接受了静脉补钙。2例患者出现永久性低钙血症。
在没有确凿证据证明预防性中央区淋巴结清扫在DTC治疗中的实际益处之前,可以避免进行该手术。口服钙和维生素D补充剂可在预防术后低钙血症以及提高安全早期出院的可能性方面发挥作用。